patients demonstrating an association with poor function and/or low numbers of NK-cells and the development of invasive aspergillosis. In both studies, as well as in the study presented by Bongomin in this Special Issue, it nevertheless remains unclear if the low number of NK-cells caused Aspergillus disease to develop. The challenge to be aimed for is to perform longitudinal clinical studies in well-defined patient groups to demonstrate a causative relationship between abnormal lymphocyte subsets and the development of CPA.
The increased insight in the characteristics of polysaccharides in the fungal cell wall, its recognition by specific pathogen receptors, and the downstream signalling resulting in either up-or down-regulation of inflammatory pathways is the subject of the review by Snarr et al. in this Special Issue [9] . In addition, the authors refer to the promising potential of this new knowledge with respect to the development of antifungals with a new mode of action and the use of immunosuppressive fungal polysaccharides in the treatment of inflammatory disorders as rheumatoid arthritis. On the other hand, Hernandez-Chavez et al. present us with a clearly written overview of how fungal cells have evolved several strategies to avoid recognition by immune cells, including the modulation of the amount of certain cell wall components (e.g., polysaccharides) or their accessibility on the fungal cell surface [10] .
The ability of C. albicans to form biofilms on the surfaces of medical and prosthetic devices, as well as on host epithelial and endothelial layers, is strongly related to a worse outcome [11] . Candida biofilms are notoriously resistant to antifungal therapy and severely compromise effective antifungal activity by phagocytes. Two papers in this Special Issue focus on specific antifungal immune mechanisms being impaired when confronted with C. albicans growing in biofilms. Kernien et al. demonstrate how various clinical C. albicans isolates forming biofilms inhibit the release of neutrophil extracellular traps (NETs) [12] . This inhibition was shown early in the formation of the biofilm before the development of long hyphal structures known to result in "frustrated" phagocytosis and release of NETs. Alonso et al. demonstrated an impaired migration of macrophages towards C. albicans growing in a biofilm compared to planktonic Candida cells [13] . Mannans in the fungal cell wall and/or secreted in the extracellular matrix seem to inhibit NET formation [14] , while the impaired macrophage migration is not dependent on the presence of mannans. This is another example of how fungal polysaccharides play various and sometimes contradictory roles in the host-fungus interaction.
Ongoing exploration and understanding of those immunological pathways is needed to ultimately lead to new directions in the development of immunotherapeutic strategies to spot the invading fungus early, leaving it no escape. Novel immunotherapeutic approaches are urgently needed, as the classes of antifungal drugs are restricted, and, even with the arrival of the newer ones, the prognosis for patients with fungal infection is still poor. A recent review by Armstrong-James and colleagues show the progress made in adjunctive antifungal strategies such as cytokine therapy, vaccines, and cellular immunotherapy [15] .
I would like to take the opportunity to express my gratitude to our colleague experts who contributed to this Special Issue resulting in a collection of excellent papers summarizing current concepts and understanding as well as the latest insights obtained in the host-fungus interactions.
